drugset / Trial / NCT05852769
A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants
NaSequentialOpen-labelTreatment
Summary
This study is designed to assess the effect of BMS-986196 on the drug levels of caffeine, montelukast, flurbiprofen, omeprazole, midazolam, digoxin, and pravastatin in healthy participants.
Timeline
- Start
- 2023-05-31
- Primary completion
- 2023-08-24
- Completion
- 2023-08-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986196 | Unknown | — | — |
| Subject | Caffeine | Small molecule | — | — |
| Subject | Digoxin | Other / unclassified | — | — |
| Subject | Flurbiprofen | Small molecule | — | — |
| Subject | Midazolam | Small molecule | — | — |
| Subject | Montelukast | Other / unclassified | — | — |
| Subject | Omeprazole | Other / unclassified | — | — |
| Subject | Pravastatin | Small molecule | — | — |
Indications
No indication recorded.